PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
0.760
-0.003 (-0.35%)
At close: Apr 28, 2026, 4:00 PM EDT
0.731
-0.029 (-3.82%)
After-hours: Apr 28, 2026, 4:56 PM EDT
PharmaCyte Biotech Employees
PharmaCyte Biotech had 2 employees as of April 30, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,743,213
Market Cap
8.16M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| TransCode Therapeutics | 12 |
| Processa Pharmaceuticals | 12 |
| MetaVia | 8 |
| Immuron | 7 |
| Indaptus Therapeutics | 5 |
| Acurx Pharmaceuticals | 4 |
| Silo Pharma | 3 |
PMCB News
- 5 months ago - PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment - Business Wire
- 8 months ago - PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications - Business Wire
- 8 months ago - PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing - Business Wire
- 9 months ago - PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Business Wire
- 2 years ago - MyMD Pharmaceuticals Secures Strategic Investments - Business Wire
- 2 years ago - PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease - Business Wire
- 2 years ago - PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc. - Business Wire
- 2 years ago - PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology - Business Wire